NREP
NEW REPRESENTATIVE AT IB RECEIVED
07/30/2026
Back to search
Official data from USPTO
RIVOPHARM
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
35
Latest update
07/30/2026
Trademark type
Word
Nice classes
5
Filing date
07/25/2006
Registration date
11/20/2007
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
06/27/2014
Last transaction
07/30/2026
Responsible office
United States Patent and Trademark Office
Status code
709
Official register
Principal Register
Drawing code
4
Owner type
99
Owner location
CH-6928 Manno, CH
Examiner
BELZER, LYDIA M
Law office
L80
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
RIVOPHARM S.A.
Representatives
RIVOPHARM SA
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceutical preparationsboth prescription and over-the-counternamely pharmaceutical preparations for peptic ulcer and gastroesophageal reflux disease (GORD)propulsivesintestinal anti-infectivesintestinal anti-inflammatory agentsoral pharmaceutical preparations for lowering blood glucoseVitamin A and Dmixed vitamin preparations consisting of vitamins A and Dvitamin and mineral preparations for medical usevitamin C in the nature of ascorbic acidmixed vitamin preparations consisting partially of Vitamin Ccalcium supplementsmineral supplementsanti-thrombotic agentsintravenous solutionscardiac glycosidesclass I and class III anti-arrhythmicspharmaceutical preparations for cardiac stimulation excluding cardiac glycosidesVasodilators used in the treatment of cardiac diseasesanti-adrenergic agentspharmaceutical preparations for acting on arteriolar smooth muscleBeta blocking agentsSelective calcium channel blockerspharmaceutical preparations in the nature of Angiotensin Converting Enzyme inhibitorspharmaceutical preparations in the nature of Angiotensin Converting Enzyme inhibitors combined with other pharmaceutical preparationsanti-fungals for systemic useanti-infectives and antisepticsexcluding those combined with corticosteroidsoxytocicsplain corticosteroids for systemic usethyroid preparationsanti-thyroid preparationstetracyclines preparationsmacrolideslincosamides and streptograminsaminoglycoside antibacterialsquinolone antibacterialsantimycotics for systemic usedirect acting antiviralsimmune serabacterial vaccinesalkylating agentsanti-metabolitesplant alkaloidscytotoxic antibioticshormone antagonists and related agentsnamely anti-estrogensanti-androgens and enzyme inhibitorsimmunosuppressive agentsanti-inflammatory and anti-rheumatic preparationsnon-steroids in the nature of butylpyrazolidinesacetic acid derivativesoxicamspropionic acid derivativesfenamatesCoxibsmuscle relaxantsperipherally acting agents in the nature of curare alkaloids and choline derivativesantigout preparationsanalgesics and antipyretics preparationsanti-migraine preparationsanti-epileptic preparationsanti-cholinergic agentsdopaminergic agentsanti-psychoticsanxiolyticshypnotics and sedativesantidepressantsparasympathomimeticsagents for use against amoebiasis and other protozoal diseasesanti-malarial preparationadrenergicsinhalant anestheticsadrenergics for systemic useantihistamines for systemic usediuretic agents
Publications
History of USPTO decisions and trademark events.
35 publications found
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
11/03/2017
GPNX
NOTIFICATION PROCESSED BY IB
10/13/2017
RFNT
REFUSAL PROCESSED BY IB
12/09/2016
INNT
TOTAL INVALIDATION PROCESSED BY THE IB
07/24/2015
INTS
TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
07/06/2015
INPC
INVALIDATION PROCESSED
07/06/2015
INTR
TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
02/27/2015
C71T
CANCELLED SECTION 71
06/27/2014
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
06/05/2009
FICS
FINAL DISPOSITION NOTICE SENT TO IB
02/27/2008
FIMP
FINAL DISPOSITION PROCESSED
02/27/2008
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
02/20/2008
R.PR
REGISTERED-PRINCIPAL REGISTER
11/20/2007
PUBO
PUBLISHED FOR OPPOSITION
09/04/2007
NPUB
NOTICE OF PUBLICATION
08/15/2007
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
05/29/2007
ALIE
ASSIGNED TO LIE
05/29/2007
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
05/10/2007
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
04/18/2007
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
04/18/2007
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
04/18/2007
CNRT
NON-FINAL ACTION MAILED
02/06/2007
CNRT
NON-FINAL ACTION WRITTEN
02/05/2007
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
01/15/2007
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
01/15/2007
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
01/15/2007
RFNT
REFUSAL PROCESSED BY IB
01/05/2007
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
12/18/2006
RFRR
REFUSAL PROCESSED BY MPU
12/18/2006
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
12/14/2006
CNRT
NON-FINAL ACTION WRITTEN
12/13/2006
DOCK
ASSIGNED TO EXAMINER
12/06/2006
NWAP
NEW APPLICATION ENTERED
09/08/2006
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
09/07/2006
Continuous trademark protection
Get notified about every new filing that threatens RIVOPHARM or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.